ARST1321: Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC#737754, IND#118613)

The Project Every Child Protocol: A Registry, Eligibility, Screening, Biology and Outcome Study

A Randomized Phase III Study of Brentuximab Vedotin (Bv, IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse in Childhood B-Lymphoblastic Leukemia (B-ALL)

ABTR01B1: Children's Oncology Group protocol for collecting and banking pediatric research specimens including rare pediatric tumors

Lung Tumors in Children: The international pleuropulmonary blastoma (PPB) registry

ALTEO5N1: UMBRELLA LONG-TERM FOLLOW-UP PROTOCOL

Kidney Tumor in Children (AREN03B2): Renal tumors classification, biology and banking study

COG ALTE07C1: Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

A randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749410), or Crizotinib (NSC# 749005, commercially labeled) in Combination with Chemotherapy for Newly Diagnosed Patients with Anaplastic Lymphoma (ALCL) IND#